On Invalid Date, Virpax Pharmaceuticals (NASDAQ: VRPX) reported Q4 2023 earnings per share (EPS) of -$3.87, up 49.42% year over year. Total Virpax Pharmaceuticals earnings for the quarter were -$4.56 million. In the same quarter last year, Virpax Pharmaceuticals's earnings per share (EPS) was -$2.59.
As of Q2 2024, Virpax Pharmaceuticals's earnings has grown year over year. Virpax Pharmaceuticals's earnings in the past year totalled -$15.19 million.
What is VRPX's earnings date?
Virpax Pharmaceuticals's earnings date is Invalid Date. Add VRPX to your watchlist to be reminded of VRPX's next earnings announcement.
What was VRPX's revenue last quarter?
On Invalid Date, Virpax Pharmaceuticals (NASDAQ: VRPX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Virpax Pharmaceuticals's revenue was $0.00.
What was VRPX's revenue growth in the past year?
As of Q2 2024, Virpax Pharmaceuticals's revenue has grown null year over year. Virpax Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.